SCHEMBL308093

SCHEMBL308093

O=Cc1cc(C=O)cc(C=O)c1

nearest known ligand 0.56

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.47
CYP2A6 P11509 3/20 0.47
KDM4E B2RXH2 1/20 0.43
PTGS2 P35354 1/20 0.43
RAB9A P51151 1/20 0.43
HSD17B10 Q99714 1/20 0.42
ALDH5A1 P51649 1/20 0.42
ABAT P80404 1/20 0.42
TSHR P16473 1/20 0.38
XDH P47989 1/20 0.37
SRC P12931 1/20 0.37
TYR P14679 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16152241 0.89 ALDH1A1 (0.40) ALDH1A1CYP2A6KDM4EPTGS2RAB9A
SCHEMBL3477069 0.83 HSD17B10 (0.52) ALDH1A1CYP2A6HSD17B10TSHRTYR
SCHEMBL646947 0.83 ALDH1A1 (0.56) ALDH1A1CYP2A6KDM4EPTGS2RAB9A
SCHEMBL13381269 0.83 ALDH1A1 (0.42) ALDH1A1CYP2A6KDM4EPTGS2RAB9A
SCHEMBL4575600 0.83 ALDH5A1 (0.52) ALDH1A1KDM4EPTGS2RAB9AHSD17B10
SCHEMBL863565 0.83 ALDH1A1 (0.36) ALDH1A1CYP2A6KDM4EPTGS2RAB9A
SCHEMBL15715521 0.83 ALDH1A1 (0.36) ALDH1A1CYP2A6KDM4EPTGS2RAB9A
SCHEMBL16439841 0.83 ERN1 (0.41) ALDH1A1CYP2A6KDM4EPTGS2RAB9A
SCHEMBL3129625 0.83 CYP2A6 (0.52) ALDH1A1CYP2A6KDM4EPTGS2RAB9A
SCHEMBL2250492 0.83 ALDH1A1 (0.36) ALDH1A1CYP2A6KDM4EPTGS2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 720 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12638144-B2 Covalent organic frameworks THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2026-05-26 US claimed
US-12624144-B2 Method for preparing hollow covalent organic framework materials ZHEJIANG UNIVERSITY (CN) 2026-05-12 US claimed
US-12628623-B2 Selective deposition for sub 20 nm pitch EUV patterning APPLIED MATERIALS, INC. (US) 2026-05-12 US claimed
US-12610791-B2 Method of forming carbon-based spacer for EUV photoresist patterns APPLIED MATERIALS, INC. (US) 2026-04-21 US claimed
US-20260034517-A1 COVALENT ORGANIC FRAMEWORKS ON HOLLOW FIBRE SUBSTRATES WITH JANUS-LIKE CHARACTERISTICS FOR SOLVENT SEPARATION NATIONAL UNIVERSITY OF SINGAPORE (SG) 2026-02-05 US claimed
US-20260021480-A1 PRODUCTION METHOD OF POROUS MATERIALS UNIV NAT TAIWAN SCIENCE & TECHNOLOGY (TW) 2026-01-22 US claimed
WO-2025091273-A1 SILICON-CARBON NEGATIVE ELECTRODE MATERIAL, AND PREPARATION METHOD THEREFOR AND USE THEREOF 广东邦普循环科技有限公司 2025-05-08 WO claimed
US-20250066528-A1 Method for Synthesizing a Covalent Organic Framework Material YOCOF MAT SUZHOU CO LTD (CN) 2025-02-27 US claimed
EP-4511526-A1 AREA SELECTIVE CARBON-BASED FILM DEPOSITION Applied Materials, Inc. (US) 2025-02-26 EP claimed
US-20250043083-A1 REINFORCED DOUBLE-THREADED SLIDE-RING NETWORKS FOR ACCELERATED HYDROGEL DISCOVERY AND 3D-PRINTING TRUSTEES OF DARTMOUTH COLLEGE (US) 2025-02-06 US claimed
EP-2569344-B1 PRODUCTION AND USE OF BRANCHED POLYMERS COMPRISING HYDROXY GROUPS AND ACRYLATE GROUPS BASF SE (DE) 2014-07-23 EP claimed
US-8591997-B2 Process for preparing structured organic films (SOFS) via a pre-SOF XEROX CORPORATION (US) 2013-11-26 US claimed
EP-2569344-A1 PRODUCTION AND USE OF BRANCHED POLYMERS COMPRISING HYDROXY GROUPS AND ACRYLATE GROUPS BASF SE (DE) 2013-03-20 EP claimed
WO-2011141424-A1 PRODUCTION AND USE OF BRANCHED POLYMERS COMPRISING HYDROXY GROUPS AND ACRYLATE GROUPS BASF SE (DE) 2011-11-17 WO claimed
US-6828392-B2 For use as solid supports for organic synthesis, for enzymatic assays, for immobilization of biomolecules, for controlled release of drugs, and for chromatographic separations CARLSBERG A/S (DK) 2004-12-07 US claimed
US-20030096918-A1 Hydroxy and amine functionalised resins CARLSBERG A/S (DK) 2003-05-22 US claimed
EP-0551221-B1 Process for the preparation of star or network multiblock polycondensates by coupling di- or multi-adhehydes, and polycondensate thus obtained ATOCHEM ELF SA (FR) 1997-06-04 EP claimed
US-5395884-A Process for manufacturing multisequence star or network polycondensates by di- or multi-aldehyde coupling, and polycondensates obtained ELF ATOCHEM S.A. (FR) 1995-03-07 US claimed
US-5346956-A Process for manufacturing multisequence star or network polycondensates by di- or multi-aldehyde coupling, and polycondensates obtained ELF ATOCHEM S.A. (FR) 1994-09-13 US claimed
EP-0551221-A1 Process for the preparation of star or network multiblock polycondensates by coupling di- or multi-adhehydes, and polycondensate thus obtained ELF ATOCHEM S.A. (FR) 1993-07-14 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12610791-B2 Method of forming carbon-based spacer for EUV photoresist patterns EPHA2, EPHA1, CDH1 ALDH1A1 2469/4885CYP2A6 4027/4885KDM4E 1574/4885
US-12638144-B2 Covalent organic frameworks ETFB, ETFA, POF1B ALDH1A1 1570/4885CYP2A6 1574/4885KDM4E 1767/4885
US-20260021480-A1 PRODUCTION METHOD OF POROUS MATERIALS F2, F5, C9 ALDH1A1 265/4885CYP2A6 1178/4885KDM4E 1823/4885
US-12628623-B2 Selective deposition for sub 20 nm pitch EUV patterning SRPK1, EPHA4, SRPK3 ALDH1A1 3157/4885CYP2A6 3298/4885KDM4E 675/4885
US-12624144-B2 Method for preparing hollow covalent organic framework materials BTF3, BPTF, H1-2 ALDH1A1 644/4885CYP2A6 1210/4885KDM4E 2251/4885
US-20260034517-A1 COVALENT ORGANIC FRAMEWORKS ON HOLLOW FIBRE SUBSTRATES WITH JANUS-LIKE CHARACTERISTICS FOR SOLVENT SEPARATION CRBN, CPSF1, SLCO2B1 ALDH1A1 534/4885CYP2A6 1123/4885KDM4E 906/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.